Ledger.Open graph →
SEC Form D · Amendment · filed May 6, 2024

Reunion Neuroscience Management, Inc

Offering
$89.8M
Sold
$33.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
Morristown, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (28)

Alon Lazarus · Morristown, NJDirectorAnsbert Gadicke · Morristown, NJDirectorMark Theeuwes · Morristown, NJExecNathan Bryson · Morristown, NJExecGregory Mayes · Morristown, NJExec · DirectorEllen Lubman · Morristown, NJDirectorNatalie Sacks · Morristown, NJDirectorEdward Smith · Morristown, NJExecNathan Bryson · Morristown, NJExecAlon Lazarus · Morristown, NJDirectorAnsbert Gadicke · Morristown, NJDirectorEdward Smith · Morristown, NJExecMark Theeuwes · Morristown, NJExecEllen Lubman · Morristown, NJDirectorNatalie Sacks · Morristown, NJDirectorGregory Mayes · Morristown, NJExec · DirectorRobert Alexander · San Mateo, CAExecBriggs Morrison · Cambridge, MADirectorMary J. Haak-Frendscho, Ph.D · South San Francisco, CAExec · DirectorTim J. Kutzkey, Ph.D · South San Francisco, CAExecShao-Lee J. Lin, M.D., Ph.D · South San Francisco, CADirectorGregory Mckinley · Minneapolis, MNDirectorVenkateswara R. Gottipatti · FRISCO, TXExecKathleen Wood · Shorewood, WIExecSteven Bruce · Shorewood, WIDirectorLasse Clausen · GRAND CAYMAN, Cayman IslandsDirectorRobert Alexander · Boston, MAExecBriggs Morrison · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗